Güldeniz Karadeniz Çakmak

Bülent Ecevit University — Turkey

Biochemistry, Genetics and Molecular Biology · Life Sciences

23h-index1.9kcitations159works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(56), Breast Lesions and Carcinomas(29), Cancer Treatment and Pharmacology(15), Breast Implant and Reconstruction(13), Thyroid and Parathyroid Surgery(13)

Publications153 total

Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study
The Lancet Oncology·2025· 1 citedOpen Access
Role of Sentinel Lymph Node Biopsy with Blue Dye Only after Neoadjuvant Systemic Treatment in Patients with Breast Cancer Who Had Biopsy-Proven Node-Positive Disease at Admission: SENATURK-ROSANNA Study
Breast Care·2025Open Access
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study
British journal of surgery·2025· 1 cited
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients – Results from the prospective AXSANA registry trial
European Journal of Cancer·2025· 6 cited
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)
European Journal of Surgical Oncology·2025· 3 citedOpen Access
Causes of diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and electronic health records analysis in Turkiye
European Journal of Public Health·2025Open Access
Abstract P3-12-16: MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4 / iBRA-NET, NCT 05559411)
Clinical Cancer Research·2025
Abstract P3-07-10: Omitting axillary dissection in Triple-negative and HER2-overexpressed cancers After neoadjuvant Chemotherapy: OTHER-NAC Study
Clinical Cancer Research·2025
Abstract P3-07-14: Omitting axillary dissection in Triple-negative and HER2-overexpressed breast cancers with positive sentinel Lymph nOdes during upfront surgery: OTHELLO Study
Clinical Cancer Research·2025
Abstract P4-06-06: The Etiologic Causes of Diagnostic Delay in Locally Advanced Breast Cancer: _x000B_A Multicentric Nationwide Trial
Clinical Cancer Research·2025
Abstract P2-10-25: AXSANA: Status of the international prospective multicenter cohort study evaluating different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)
Clinical Cancer Research·2025
Surgical axillary staging in elderly patients with initially node-positive breast cancer after neoadjuvant chemotherapy – data from the prospective AXSANA study (NCT04373655/EUBREAST-03/AGO-B-053 study)
Senologie - Zeitschrift für Mammadiagnostik und -therapie·2025
Consequences of lost axillary markers after neoadjuvant chemotherapy in breast cancer patients – data from the prospective international AXSANA cohort study (NCT04373655)
Senologie - Zeitschrift für Mammadiagnostik und -therapie·2025
Status of the international prospective multicenter AXSANA study (NCT04373655) evaluating different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy
Senologie - Zeitschrift für Mammadiagnostik und -therapie·2025
Winter is coming: Is the shine of surgery fading?
Turkish Journal of Surgery·2025Open Access
Comparison of marking techniques for target lymph nodes in 2,596 patients with node-positive breast cancer treated with neoadjuvant chemotherapy: Results from the prospective multicenter AXSANA/EUBREAST-03/AGO-B-053 study (NCT04373655).
Journal of Clinical Oncology·2025· 1 cited
MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4/iBRA-NET/AGO-B-062, NCT 05559411).
Journal of Clinical Oncology·2025
An Investigation of TRIM36 Expression in Breast Cancer
Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi·2025Open Access
Exploring the perspectives and challenges of general surgery residents in Türkiye: Insights from a survey on surgical training
Turkish Journal of Surgery·2025· 1 citedOpen Access
Predictors of Malignancy in Patients With a Repeated Diagnosis of Bethesda Category in Thyroid Nodules Who Underwent Surgery
Diagnostic Cytopathology·2025Open Access
page 1 of 8Next →

Frequent Co-authors

Mustafa Cömert(22), Öge Taşçılar(22), Arif Emre(22), Oktay İrkörücü(17), Bülent Hamdi Uçan(15), Kemal Karakaya(15), Handan Ankaralı(11), Thorsten Kühn(9), Burak Bahadır(9), Hasan Karanlık(7), Maggie Banys‐Paluchowski(6), Jana de Boniface(6), Oreste ­Gentilini(6), Isabel T. Rubio(6), Mustafa Ümit Uğurlu(6), Serdar Özbaş(6), Maria Luisa Gasparri(5), Dawid Murawa(5), Neslihan Cabıoğlu(5), Şerefden Açıkgöz(5)